Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated Rabeprazole
Drug Design, Development and Therapy · 2023
DOI: 10.2147/dddt.s391716 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Sungyeun Bae und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Anti-Ulcer Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
- Department of Statistics, APACE, Seoul, Republic of Korea.
- Yungjin Pharmaceutical Co., Ltd, Seoul, Republic of Korea.
ORCID-Profile: Sungyeun Bae, Kyung-Sang Yu, SeungHwan Lee
Zitieren
APA
Bae, S., Kwon, J., Lee, M. H., Yu, K. S., & Lee, S. (2023). Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated Rabeprazole. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s391716
Vancouver
Bae S, Kwon J, Lee MH, Yu KS, Lee S. Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated Rabeprazole. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s391716
BibTeX
@article{Bae2023,
author = {Bae, Sungyeun and Kwon, Jihoon and Lee, Mi-Hye and Yu, Kyung-Sang and Lee, SeungHwan},
title = {Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated Rabeprazole},
journal = {Drug Design, Development and Therapy},
year = {2023},
doi = {10.2147/dddt.s391716}
}
EUVIMED